Gerberding Julie L.
- SEC CIK
- 0001628884
No open-market purchases or sales filed in the past year.
Current role at each company
- MCK McKesson CorpDirectoras of Jul 23, 2026
- HLVX HilleVax, Inc.Directoras of Sep 17, 2025
- CERN CERNER CorpDirectoras of Jun 9, 2022
- MRK Merck & Co., Inc.EVP, Chief Patient Officeras of Feb 28, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gerberding Julie L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRK Merck & Co., Inc.
EVP, Chief Patient Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Gerberding Julie L.EVP, Chief Patient Officer | SSale | −96.3K | $87.91 | −$8.46M | −71.1%39.2K after |